485
Views
74
CrossRef citations to date
0
Altmetric
Review

The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas

, &
Pages 737-753 | Received 30 Jul 2015, Accepted 26 Oct 2015, Published online: 11 Dec 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Rui Han, Xinyi Chen, Ya Li, Shunjia Zhang, Ruibai Li & Lingeng Lu. (2019) MicroRNA-34a suppresses aggressiveness of hepatocellular carcinoma by modulating E2F1, E2F3, and Caspase-3. Cancer Management and Research 11, pages 2963-2976.
Read now
Jing Xue, Jiali Yang, Meihui Luo, William C. Cho & Xiaoming Liu. (2017) MicroRNA-targeted therapeutics for lung cancer treatment. Expert Opinion on Drug Discovery 12:2, pages 141-157.
Read now
Jie Shen, Yousef Abu-Amer, Regis J. O’Keefe & Audrey McAlinden. (2017) Inflammation and epigenetic regulation in osteoarthritis. Connective Tissue Research 58:1, pages 49-63.
Read now

Articles from other publishers (71)

Christian Michael Hedrich. 2024. Epigenetics in Human Disease. Epigenetics in Human Disease 413 431 .
Mohammad Saleh Sadeghi, Mohadeseh lotfi, Narges Soltani, Elahe Farmani, Jaime Humberto Ortiz Fernandez, Sheida Akhlaghitehrani, Safaa Hallol Mohammed, Saman Yasamineh, Hesam Ghafouri Kalajahi & Omid Gholizadeh. (2023) Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review. Cancer Cell International 23:1.
Crossref
Diana Wu, Lilian U. Thompson & Elena M. Comelli. (2022) MicroRNAs: A Link between Mammary Gland Development and Breast Cancer. International Journal of Molecular Sciences 23:24, pages 15978.
Crossref
Najmeh Alsadat Abtahi, Seyed Morteza Naghib, Fatemeh Haghiralsadat & Mohammadmahdi Akbari Edgahi. (2022) Development of highly efficient niosomal systems for co-delivery of drugs and genes to treat breast cancer in vitro and in vivo. Cancer Nanotechnology 13:1.
Crossref
Mohsen Karami fath, Mehran Anjomrooz, Seyed Reza Taha, Mahdieh Shariat Zadeh, Mahya Sahraei, Raihaneh Atbaei, Andarz Fazlollahpour naghibi, Zahra Payandeh, Zobeir Rahmani & Ghasem Barati. (2022) The therapeutic effect of exosomes from mesenchymal stem cells on colorectal cancer: Toward cell-free therapy. Pathology - Research and Practice 237, pages 154024.
Crossref
Luigi Borzacchiello, Roberta Veglia Tranchese, Roberta Grillo, Roberta Arpino, Laura Mosca, Giovanna Cacciapuoti & Marina Porcelli. (2022) S-Adenosylmethionine Inhibits Colorectal Cancer Cell Migration through Mirna-Mediated Targeting of Notch Signaling Pathway. International Journal of Molecular Sciences 23:14, pages 7673.
Crossref
Yuqing Liu, Xin Cheng, Hongli Li, Shan Hui, Zheyu Zhang, Yang Xiao & Weijun Peng. (2022) Non-Coding RNAs as Novel Regulators of Neuroinflammation in Alzheimer’s Disease. Frontiers in Immunology 13.
Crossref
Fanyi Meng, Jiawei Li, Yajing Qiu, Haiyang Zhang, Hongjian Zhang & Weipeng Wang. (2022) AM22, a novel synthetic microRNA, inhibits the proliferation of colorectal cancer cells by targeting core binding factor subunit β (CBFB). Investigational New Drugs 40:3, pages 469-477.
Crossref
Sophie Mockly, Élisabeth Houbron & Hervé Seitz. (2022) A rationalized definition of general tumor suppressor microRNAs excludes miR-34a. Nucleic Acids Research 50:8, pages 4703-4712.
Crossref
Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology 397 533 .
Fanyi Meng, Yinshuang Chen, Man Yang, Hongjian Zhang & Weipeng Wang. (2021) Concomitant inhibition of B7-H3 and PD-L1 expression by a novel and synthetic microRNA delivers potent antitumor activities in colorectal tumor models. Investigational New Drugs 39:5, pages 1267-1274.
Crossref
Eric Hesse, Franz Jakob & Hanna Taipaleenmäki. (2021) Update on MicroRNA-based Treatment Strategies. Osteologie 30:03, pages 243-250.
Crossref
Konstantinos Pantos, Sokratis Grigoriadis, Penelope Tomara, Ioanna Louka, Evangelos Maziotis, Agni Pantou, Nikolaos Nitsos, Terpsithea Vaxevanoglou, Georgia Kokkali, Ashok Agarwal, Konstantinos Sfakianoudis & Mara Simopoulou. (2021) Investigating the Role of the microRNA-34/449 Family in Male Infertility: A Critical Analysis and Review of the Literature. Frontiers in Endocrinology 12.
Crossref
Silvia Martini, Valentina Zuco, Monica Tortoreto, Stefano Percio, Elisa Campi, Rihan El Bezawy, Valentina Doldi, Yosef Landesman, Marzia Pennati & Nadia Zaffaroni. (2021) miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast Cancer. Pharmaceuticals 14:6, pages 523.
Crossref
Anna Maria Grimaldi, Marco Salvatore & Mariarosaria Incoronato. (2021) miRNA-Based Therapeutics in Breast Cancer: A Systematic Review. Frontiers in Oncology 11.
Crossref
Qinghui Zheng, Mengdi Zhang, Fangfang Zhou, Long Zhang & Xuli Meng. (2021) The Breast Cancer Stem Cells Traits and Drug Resistance. Frontiers in Pharmacology 11.
Crossref
Kartik Sehgal & David A. Barbie. (2021) Targeting the mutant p53 secretome. Journal of Clinical Investigation 131:1.
Crossref
Xiaozhu Tang, Hongyan Ren, Mengjie Guo, Jinjun Qian, Ye Yang & Chunyan Gu. (2021) Review on circular RNAs and new insights into their roles in cancer. Computational and Structural Biotechnology Journal 19, pages 910-928.
Crossref
Wenwen Wang, Xiuxiu Li, Ning Ding, Jun Teng, Shen Zhang, Qin Zhang & Hui Tang. (2020) miR-34a regulates adipogenesis in porcine intramuscular adipocytes by targeting ACSL4. BMC Genetics 21:1.
Crossref
Ming Liao & Lijun Peng. (2020) MiR-206 may suppress non-small lung cancer metastasis by targeting CORO1C. Cellular & Molecular Biology Letters 25:1.
Crossref
Xiangang Cao, Qian Yang & Qing Yu. (2020) Increased Expression of miR-487b Is Associated With Poor Prognosis and Tumor Progression of HBV-Related Hepatocellular Carcinoma. Open Forum Infectious Diseases 7:12.
Crossref
Young-Ho Ahn & Yoon Ho Ko. (2020) Diagnostic and Therapeutic Implications of microRNAs in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences 21:22, pages 8782.
Crossref
Fan Zhang, Bo Wang, Tao Qin, Lu Wang, Qingqing Zhang, Ying Lu, Bo Song, Xiaotang Yu & Lianhong Li. (2020) IL-6 induces tumor suppressor protein tyrosine phosphatase receptor type D by inhibiting miR-34a to prevent IL-6 signaling overactivation. Molecular and Cellular Biochemistry 473:1-2, pages 1-13.
Crossref
Neda Mokhberian, Zohreh Bolandi, Mohamad Eftekhary, Seyed Mahmoud Hashemi, Vahid Jajarmi, Kazem Sharifi & Hossein Ghanbarian. (2020) Inhibition of miR-34a reduces cellular senescence in human adipose tissue-derived mesenchymal stem cells through the activation of SIRT1. Life Sciences 257, pages 118055.
Crossref
Thomas Andl, Kavya Ganapathy, Alexia Bossan & Ratna Chakrabarti. (2020) MicroRNAs as Guardians of the Prostate: Those Who Stand before Cancer. What Do We Really Know about the Role of microRNAs in Prostate Biology?. International Journal of Molecular Sciences 21:13, pages 4796.
Crossref
Yoshihisa Tokumaru, Eriko Katsuta, Masanori Oshi, Judith C. Sporn, Li Yan, Lan Le, Nobuhisa Matsuhashi, Manabu Futamura, Yukihiro Akao, Kazuhiro Yoshida & Kazuaki Takabe. (2020) High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer. International Journal of Molecular Sciences 21:9, pages 3045.
Crossref
Sarah Bajan & Gyorgy Hutvagner. (2020) RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs. Cells 9:1, pages 137.
Crossref
Francesca Motta, Maria Cristina Carena, Carlo Selmi & Matteo Vecellio. (2020) MicroRNAs in ankylosing spondylitis: Function, potential and challenges. Journal of Translational Autoimmunity 3, pages 100050.
Crossref
Yuxiang Fu, Liewen Lin & Ligang Xia. (2019) MiR-107 function as a tumor suppressor gene in colorectal cancer by targeting transferrin receptor 1. Cellular & Molecular Biology Letters 24:1.
Crossref
Kai-li Zhang, Qian-qian Shen, Yan-fen Fang, Yi-ming Sun, Jian Ding & Yi Chen. (2019) AZD9291 inactivates the PRC2 complex to mediate tumor growth inhibition. Acta Pharmacologica Sinica 40:12, pages 1587-1595.
Crossref
Arturo López Castel, Sarah Joann Overby & Rubén Artero. (2019) MicroRNA-Based Therapeutic Perspectives in Myotonic Dystrophy. International Journal of Molecular Sciences 20:22, pages 5600.
Crossref
Frank J. Slack & Arul M. Chinnaiyan. (2019) The Role of Non-coding RNAs in Oncology. Cell 179:5, pages 1033-1055.
Crossref
Jieni Xu, Jingjing Sun, Pui Yan Ho, Zhangyi Luo, Weina Ma, Wenchen Zhao, Sanjay B. Rathod, Christian A. Fernandez, Raman Venkataramanan, Wen Xie, Ai-Ming Yu & Song Li. (2019) Creatine based polymer for codelivery of bioengineered MicroRNA and chemodrugs against breast cancer lung metastasis. Biomaterials 210, pages 25-40.
Crossref
Rachel E. Sexton, Gabriel Mpilla, Steve Kim, Philip A. Philip & Asfar S. Azmi. (2019) Ras and exosome signaling. Seminars in Cancer Biology 54, pages 131-137.
Crossref
Christelle En Lin Chua & Bor Luen Tang. (2018) miR-34a in Neurophysiology and Neuropathology. Journal of Molecular Neuroscience 67:2, pages 235-246.
Crossref
Christian Michael Hedrich. 2019. Pharmacoepigenetics. Pharmacoepigenetics 597 608 .
Despoina Kalapanida, Flora Zagouri, Maria Gazouli, Eleni Zografos, Constantine Dimitrakakis, Spyridon Marinopoulos, Aris Giannos, Theodoros N. Sergentanis, Efstathios Kastritis, Evangelos Terpos & Meletios-Athanasios Dimopoulos. (2018) Evaluation of pre-mir-34a rs72631823 single nucleotide polymorphism in triple negative breast cancer: A case-control study. Oncotarget 9:97, pages 36906-36913.
Crossref
Radha D. Singh, Ruchita Shandilya, Arpit Bhargava, Rajat Kumar, Rajnarayan Tiwari, Koel Chaudhury, Rupesh K. Srivastava, Irina Y. Goryacheva & Pradyumna K. Mishra. (2018) Quantum Dot Based Nano-Biosensors for Detection of Circulating Cell Free miRNAs in Lung Carcinogenesis: From Biology to Clinical Translation. Frontiers in Genetics 9.
Crossref
Hui Lyu, Jingcao Huang, Zhimin He & Bolin Liu. (2018) Targeting of HER3 with Functional Cooperative miRNAs Enhances Therapeutic Activity in HER2-Overexpressing Breast Cancer Cells. Biological Procedures Online 20:1.
Crossref
Gengze WuPedro A. JoseChunyu Zeng. (2018) Noncoding RNAs in the Regulatory Network of Hypertension. Hypertension 72:5, pages 1047-1059.
Crossref
Lan Lan, Yue Wang, Zhanyu Pan, Bin Wang, Zhensong Yue, Zhansheng Jiang, Ling Li, Cong Wang & Hongmei Tang. (2018) Rhamnetin induces apoptosis in human breast cancer cells via the miR‑34a/Notch‑1 signaling pathway. Oncology Letters.
Crossref
Ritu Goyal, Chintan H. Kapadia, Jilian R. Melamed, Rachel S. Riley & Emily S. Day. (2018) Layer-by-Layer Assembled Gold Nanoshells for the Intracellular Delivery of miR-34a. Cellular and Molecular Bioengineering 11:5, pages 383-396.
Crossref
Kenneth KW To, Christy WS Tong, Mingxia Wu & William CS Cho. (2018) MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside. World Journal of Gastroenterology 24:27, pages 2949-2973.
Crossref
Brian D. Adams, Hannah Arem, Monica J. Hubal, Brenda Cartmel, Fangyong Li, Maura Harrigan, Tara Sanft, Christopher J. Cheng, Lajos Pusztai & Melinda L. Irwin. (2018) Exercise and weight loss interventions and miRNA expression in women with breast cancer. Breast Cancer Research and Treatment 170:1, pages 55-67.
Crossref
Julian Gomez-Cambronero, Kristen Fite & Taylor E. Miller. (2018) How miRs and mRNA deadenylases could post-transcriptionally regulate expression of tumor-promoting protein PLD. Advances in Biological Regulation 68, pages 107-119.
Crossref
Humberto J. Ferreira & Manel Esteller. (2018) Non-coding RNAs, epigenetics, and cancer: tying it all together. Cancer and Metastasis Reviews 37:1, pages 55-73.
Crossref
Yunfeng Fu, Chengyuan Li, Yanwei Luo, Lian Li, Jing Liu & Rong Gui. (2018) Silencing of Long Non-coding RNA MIAT Sensitizes Lung Cancer Cells to Gefitinib by Epigenetically Regulating miR-34a. Frontiers in Pharmacology 9.
Crossref
Christian M. Hedrich. 2018. Epigenetics in Human Disease. Epigenetics in Human Disease 387 405 .
Zhixiong Tang, Huiling Qiu, Lan Luo, Nian Liu, Jiasheng Zhong, Kang Kang & Deming Gou. (2017) miR‐34b Modulates Skeletal Muscle Cell Proliferation and Differentiation. Journal of Cellular Biochemistry 118:12, pages 4285-4295.
Crossref
Ammad Farooqi, Sobia Tabassum & Aamir Ahmad. (2017) MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers. International Journal of Molecular Sciences 18:10, pages 2089.
Crossref
Veronika Holubekova, Andrea Mendelova, Karin Jasek, Sandra Mersakova, Pavol Zubor & Zora Lasabova. (2017) Epigenetic regulation by DNA methylation and miRNA molecules in cancer. Future Oncology 13:25, pages 2217-2222.
Crossref
Tina Catela Ivkovic, Gjendine Voss, Helena Cornella & Yvonne Ceder. (2017) microRNAs as cancer therapeutics: A step closer to clinical application. Cancer Letters 407, pages 113-122.
Crossref
Verena Stiegelbauer, Petra Vychytilova-Faltejskova, Michael Karbiener, Anna-Maria Pehserl, Andreas Reicher, Margit Resel, Ellen Heitzer, Cristina Ivan, Marc Bullock, Hui Ling, Alexander Deutsch, Annika Wulf-Goldenberg, Jan Basri Adiprasito, Herbert Stoeger, Johannes Haybaeck, Marek Svoboda, Michael Stotz, Gerald Hoefler, Ondrej Slaby, George Adrian Calin, Armin Gerger & Martin Pichler. (2017) miR-196b-5p Regulates Colorectal Cancer Cell Migration and Metastases through Interaction with HOXB7 and GALNT5. Clinical Cancer Research 23:17, pages 5255-5266.
Crossref
H. Peter Rodemann, Niloy Ranjan Datta & Stephan Bodis. (2017) Molecular radiation biology/oncology and its impact on preclinical and clinical research in radiotherapy. Radiotherapy and Oncology 124:3, pages 339-343.
Crossref
Christian Michael Hedrich. (2017) Epigenetics in SLE. Current Rheumatology Reports 19:9.
Crossref
Y-L Li, X-M Liu, C-Y Zhang, J-B Zhou, Y Shao, C Liang, H-M Wang, Z-Y Hua, S-D Lu & Z-L Ma. (2017) MicroRNA-34a/EGFR axis plays pivotal roles in lung tumorigenesis. Oncogenesis 6:8, pages e372-e372.
Crossref
Ken-ichi Takayama, Aya Misawa & Satoshi Inoue. (2017) Significance of microRNAs in Androgen Signaling and Prostate Cancer Progression. Cancers 9:12, pages 102.
Crossref
Deniz Isin, Ece Eksin & Arzum Erdem. (2017) Graphene oxide modified single-use electrodes and their application for voltammetric miRNA analysis. Materials Science and Engineering: C 75, pages 1242-1249.
Crossref
Longchang Jiang & Heiko Hermeking. (2017) miR-34a and miR-34b/c Suppress Intestinal Tumorigenesis . Cancer Research 77:10, pages 2746-2758.
Crossref
Makon-Sébastien Njock & Jason E. Fish. (2017) Endothelial miRNAs as Cellular Messengers in Cardiometabolic Diseases. Trends in Endocrinology & Metabolism 28:3, pages 237-246.
Crossref
Marisa Shiina, Yutaka Hashimoto, Taku Kato, Soichiro Yamamura, Yuichiro Tanaka, Shahana Majid, Sharanjot Saini, Shahryari Varahram, Priyanka Kulkarni, Pritha Dasgupta, Yozo Mitsui, Mitsuho Sumida, Laura Tabatabai, Guoren Deng, Deepak Kumar & Rajvir Dahiya. (2016) Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians. Oncotarget 8:5, pages 8356-8368.
Crossref
Wei XieLei WangHalei ShengJing QiuDi ZhangLe ZhangFan YangDahai TangKebin Zhang. (2017) Metformin Induces Growth Inhibition and Cell Cycle Arrest by Upregulating MicroRNA34a in Renal Cancer Cells. Medical Science Monitor 23, pages 29-37.
Crossref
Mathieu Neault, Florence Couteau, Éric Bonneau, Vincent De Guire & Frédérick A. Mallette. 2017. MiRNAs in Aging and Cancer. MiRNAs in Aging and Cancer 27 98 .
Daniel A. Lorenz & Amanda L. Garner. 2018. RNA Therapeutics. RNA Therapeutics 79 110 .
J. MERHAUTOVÁ, P. VYCHYTILOVÁ-FALTEJSKOVÁ, R. DEMLOVÁ & O. SLABÝ. (2016) Systemic Administration of miRNA Mimics by Liposomal Delivery System in Animal Model of Colorectal Carcinoma. Physiological Research, pages S481-S488.
Crossref
Jiachun Han, Jiang Shu & Juan Cui. (2016) A new system for human microRNA functional evaluation and network. A new system for human microRNA functional evaluation and network.
Shubin HongShuang YuJin LiYali YinYujie LiuQuan ZhangHongyu GuanYanbing LiHaipeng Xiao. (2016) MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway. Thyroid 26:12, pages 1733-1743.
Crossref
Lin Deng, Angela C. Bradshaw & Andrew H. Baker. (2016) Role of noncoding RNA in vascular remodelling. Current Opinion in Lipidology 27:5, pages 439-448.
Crossref
Jana Merhautova, Regina Demlova & Ondrej Slaby. (2016) MicroRNA-Based Therapy in Animal Models of Selected Gastrointestinal Cancers. Frontiers in Pharmacology 7.
Crossref
V. Taucher, H. Mangge & J. Haybaeck. (2016) Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application. Cellular Oncology 39:4, pages 295-318.
Crossref
Marzena Ciechomska & Steven O’Reilly. (2016) Epigenetic Modulation as a Therapeutic Prospect for Treatment of Autoimmune Rheumatic Diseases. Mediators of Inflammation 2016, pages 1-11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.